Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Northeastern University
- Zintellect
- Nanyang Technological University
- Center for Drug Evaluation and Research (CDER)
- Delaware State University
- Ellison Institute of Technology
- Harvard University
- Humboldt-Universität zu Berlin
- National Institute of Allergy and Infectious Diseases, NIH
- National University of Singapore
- The University of Queensland
- UNIVERSITY OF SURREY
- University of British Columbia
- University of Surrey
- 4 more »
- « less
-
Field
-
spectroscopy, mass spectrometry, elemental analysis, HPLC, optical spectroscopy analysis, single-crystal XRD, XPS, IR, TGA, DSC, and some magnetic measurements including ESR, superconducting quantum interference
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
system level simulation studies • Propose and innovate solutions for operational challenges in hardware such as common mode noise, electromagnetic interference, filter design, etc for better motor and
-
may include electromagnetic ISAC channel modelling, waveform and transceiver design, sensing signal processing, AI/ML-enabled radio interfaces, MIMO beamforming and channel estimation, interference
-
may include electromagnetic ISAC channel modelling, waveform and transceiver design, sensing signal processing, AI/ML-enabled radio interfaces, MIMO beamforming and channel estimation, interference
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
experience in wireless power transfer, electromagnetic compatibility/interference, electromagnetic shielding, antenna/coil design, or related areas. Experience in electromagnetic simulation tools Experience in
-
National Institute of Allergy and Infectious Diseases, NIH | Rockville, Maryland | United States | about 1 month ago
sporozoite challenge in vivo (Dacon et al., Science 2025). Importantly, these mAbs do not interfere with the current malaria vaccines, RTS,S/AS01 and R21/Matrix M, and they are now lead candidates for